Literature DB >> 8301441

Pathophysiology of congenital diaphragmatic hernia. V. Effect of exogenous surfactant therapy on gas exchange and lung mechanics in the lamb congenital diaphragmatic hernia model.

D T Wilcox1, P L Glick, H Karamanoukian, J Rossman, F C Morin, B A Holm.   

Abstract

The aim of this study was to assess the impact of surfactant deficiency on the pathophysiology of congenital diaphragmatic hernia (CDH). Pregnant ewes were operated on at 80 days of gestation for creation of a diaphragmatic hernia in the lambs. Twenty-one lambs survived to be delivered by cesarean section and were studied. Compliance was improved when surface tension effects were removed by saline solution in lungs of both control animals and lambs with CDH; however, the lungs of the lambs with CDH still had significantly impaired compliance. In a second series of experiments, two groups were studied: a surfactant-treated and a control, nontreated group. Surfactant was given prophylactically into the liquid-filled lungs before the first breath. All lambs were paralyzed and sedated and their lungs mechanically ventilated with 100% oxygen for 30 minutes; gas exchange was then assessed, pressure-volume data were obtained, and compliance was calculated. Surfactant significantly improved gas exchange; arterial oxygen pressure increased from 39 +/- 11.4 to 316 +/- 53.6 mm Hg, arterial carbon dioxide pressure decreased from 148 to 63 mm Hg, and pH increased from 6.87 to 7.16 (p < 0.001). Lung volume at 25 cm H2O, functional residual capacity, and compliance were all increased (p < 0.02). Thus, in the CDH lamb model, pulmonary mechanics are impaired by both parenchymal and surfactant abnormalities. Both lung mechanics and gas exchange are markedly improved by exogenous surfactant therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8301441     DOI: 10.1016/s0022-3476(94)70322-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  New targets for surfactant replacement therapy: experimental and clinical aspects.

Authors:  B Robertson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

2.  Historical aspects of congenital diaphragmatic hernia.

Authors:  P Puri; T Wester
Journal:  Pediatr Surg Int       Date:  1997-02       Impact factor: 1.827

Review 3.  Making the most out of the least: new insights into congenital diaphragmatic hernia.

Authors:  H L Karamanoukian; S J O'Toole; B A Holm; P L Glick
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

Review 4.  Surfactant therapy: the current practice and the future trends.

Authors:  Khalid Altirkawi
Journal:  Sudan J Paediatr       Date:  2013

5.  Surfactant levels in congenital diaphragmatic hernia.

Authors:  Marcus Davey
Journal:  PLoS Med       Date:  2007-07-31       Impact factor: 11.069

Review 6.  What's new in surfactant? A clinical view on recent developments in neonatology and paediatrics.

Authors:  Jasper V Been; Luc J I Zimmermann
Journal:  Eur J Pediatr       Date:  2007-05-22       Impact factor: 3.183

7.  Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease--research or clinical application?

Authors:  A Greenough
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.